Is Sight Sciences Stock a Good Investment?

Sight Sciences Investment Advice

  SGHT
To provide specific investment advice or recommendations on Sight Sciences stock, we recommend investors consider the following general factors when evaluating Sight Sciences. This will help you to make an informed decision on whether to include Sight Sciences in one of your diversified portfolios:
  • Examine Sight Sciences' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Sight Sciences' leadership team and their track record. Good management can help Sight Sciences navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Sight Sciences' business and its evolving consumer preferences.
  • Compare Sight Sciences' performance and market position to its competitors. Analyze how Sight Sciences is positioned in terms of product offerings, innovation, and market share.
  • Check if Sight Sciences pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Sight Sciences' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Sight Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Sight Sciences is a good investment.
 
Sell
 
Buy
Strong Hold
We provide advice to complement the current expert consensus on Sight Sciences. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Sight Sciences is not overpriced, please validate all Sight Sciences fundamentals, including its price to book, current ratio, retained earnings, as well as the relationship between the net income and target price . Given that Sight Sciences has a number of shares shorted of 1.23 M, we advise you to double-check Sight Sciences market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.

Market Performance

OKDetails

Volatility

RiskyDetails

Hype Condition

Under hypedDetails

Current Valuation

Fairly ValuedDetails

Odds Of Distress

Quite HighDetails

Economic Sensitivity

Responds to the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Sight Sciences Stock

Researching Sight Sciences' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 21.0% of the company outstanding shares are owned by corporate insiders. The book value of Sight Sciences was at this time reported as 1.51. The company recorded a loss per share of 0.98. Sight Sciences had not issued any dividends in recent years.
To determine if Sight Sciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Sight Sciences' research are outlined below:
Sight Sciences had very high historical volatility over the last 90 days
Sight Sciences has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 79.87 M. Net Loss for the year was (51.51 M) with profit before overhead, payroll, taxes, and interest of 66.91 M.
Sight Sciences currently holds about 220.1 M in cash with (22.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Sight Sciences has a frail financial position based on the latest SEC disclosures
Roughly 21.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Disposition of 40000 shares by Badawi David of Sight Sciences at 0.12 subject to Rule 16b-3

Sight Sciences Quarterly Cost Of Revenue

2.41 Million

Sight Sciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Sight Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Sight Sciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
11th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
11th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Sight Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Sight Sciences' investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-08-03
2023-06-30-0.34-0.30.0411 
2023-05-04
2023-03-31-0.39-0.350.0410 
2024-08-01
2024-06-30-0.3-0.250.0516 
2024-05-02
2024-03-31-0.28-0.33-0.0517 
2023-11-07
2023-09-30-0.32-0.270.0515 
2022-03-24
2021-12-31-0.39-0.340.0512 
2025-03-05
2024-12-31-0.176-0.23-0.05430 
2021-11-10
2021-09-30-0.37-0.43-0.0616 

Sight Sciences Target Price Consensus

Sight target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Sight Sciences' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   8  Buy
Most Sight analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Sight stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Sight Sciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Sight Sciences Target Price Projection

Sight Sciences' current and average target prices are 3.50 and 3.42, respectively. The current price of Sight Sciences is the price at which Sight Sciences is currently trading. On the other hand, Sight Sciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Sight Sciences Market Quote on 19th of July 2025

Low Price3.5Odds
High Price3.61Odds

3.5

Target Price

Analyst Consensus On Sight Sciences Target Price

Low Estimate3.11Odds
High Estimate3.79Odds

3.4167

Historical Lowest Forecast  3.11 Target Price  3.42 Highest Forecast  3.79
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Sight Sciences and the information provided on this page.

Sight Sciences Analyst Ratings

Sight Sciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Sight Sciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Sight Sciences' financials, market performance, and future outlook by experienced professionals. Sight Sciences' historical ratings below, therefore, can serve as a valuable tool for investors.

Know Sight Sciences' Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Sight Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sight Sciences backward and forwards among themselves. Sight Sciences' institutional investor refers to the entity that pools money to purchase Sight Sciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Acadian Asset Management Llc2025-03-31
432.5 K
D. E. Shaw & Co Lp2025-03-31
420.9 K
Morgan Stanley - Brokerage Accounts2025-03-31
338.7 K
Northern Trust Corp2025-03-31
313.5 K
Dimensional Fund Advisors, Inc.2025-03-31
297.9 K
National Asset Management Inc2024-12-31
243.1 K
Charles Schwab Investment Management Inc2025-03-31
223.7 K
Citadel Advisors Llc2025-03-31
221 K
Squarepoint Ops Llc2025-03-31
166.4 K
Kck Ltd2024-12-31
4.4 M
Long Focus Capital Management, Llc2025-03-31
3.1 M
Note, although Sight Sciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Sight Sciences' market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 183.03 M.

Market Cap

173.36 Million

Sight Sciences' profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(0.36)(0.38)
Return On Capital Employed(0.40)(0.42)
Return On Assets(0.36)(0.38)
Return On Equity(0.59)(0.56)
The company has Profit Margin (PM) of (0.63) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.79) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.79.
Determining Sight Sciences' profitability involves analyzing its financial statements and using various financial metrics to determine if Sight Sciences is a good buy. For example, gross profit margin measures Sight Sciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Sight Sciences' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Sight Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sight Sciences. Check Sight Sciences' Beneish M Score to see the likelihood of Sight Sciences' management manipulating its earnings.

Evaluate Sight Sciences' management efficiency

Sight Sciences has return on total asset (ROA) of (0.2177) % which means that it has lost $0.2177 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5288) %, meaning that it created substantial loss on money invested by shareholders. Sight Sciences' management efficiency ratios could be used to measure how well Sight Sciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.38 in 2025. Return On Capital Employed is likely to drop to -0.42 in 2025. At this time, Sight Sciences' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 46.7 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 12.3 M in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 1.75  0.97 
Tangible Book Value Per Share 1.75  0.97 
Enterprise Value Over EBITDA(2.23)(2.34)
Price Book Value Ratio 2.09  2.19 
Enterprise Value Multiple(2.23)(2.34)
Price Fair Value 2.09  2.19 
Enterprise Value102.5 M97.4 M
Examining the leadership quality of Sight Sciences offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Beta
2.452

Basic technical analysis of Sight Stock

As of the 19th of July, Sight Sciences has the Semi Deviation of 4.55, risk adjusted performance of 0.147, and Coefficient Of Variation of 671.67. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sight Sciences, as well as the relationship between them.

Sight Sciences' insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sight Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sight Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sight Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Badawi David 2 days ago
Disposition of 40000 shares by Badawi David of Sight Sciences at 0.12 subject to Rule 16b-3
 
Badawi David over two weeks ago
Disposition of 5679 shares by Badawi David of Sight Sciences at 4.174 subject to Rule 16b-3
 
Matthew Link over two weeks ago
Disposition of 4889 shares by Matthew Link of Sight Sciences at 4.098 subject to Rule 16b-3
 
Encrantz Staffan over three weeks ago
Acquisition by Encrantz Staffan of 120000 shares of Sight Sciences at 2.53 subject to Rule 16b-3
 
Jeremy Hayden over a month ago
Disposition of 1810 shares by Jeremy Hayden of Sight Sciences at 3.259 subject to Rule 16b-3
 
Matthew Link over a month ago
Acquisition by Matthew Link of 172043 shares of Sight Sciences subject to Rule 16b-3
 
Encrantz Staffan over a month ago
Acquisition by Encrantz Staffan of 21674 shares of Sight Sciences at 4.172 subject to Rule 16b-3
 
Encrantz Staffan over a month ago
Acquisition by Encrantz Staffan of 25230 shares of Sight Sciences at 3.967 subject to Rule 16b-3
 
Encrantz Staffan over a month ago
Acquisition by Encrantz Staffan of 30799 shares of Sight Sciences at 3.878 subject to Rule 16b-3
 
Encrantz Staffan over a month ago
Acquisition by Encrantz Staffan of 42753 shares of Sight Sciences at 3.67 subject to Rule 16b-3
 
Encrantz Staffan over a month ago
Acquisition by Encrantz Staffan of 60128 shares of Sight Sciences at 3.588 subject to Rule 16b-3
 
Encrantz Staffan over a month ago
Acquisition by Encrantz Staffan of 26715 shares of Sight Sciences at 3.516 subject to Rule 16b-3

Sight Sciences' Outstanding Corporate Bonds

Sight Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sight Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sight bonds can be classified according to their maturity, which is the date when Sight Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Sight Sciences' technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Sight Sciences' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Sight Sciences' intraday indicators

Sight Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sight Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Sight Sciences time-series forecasting models is one of many Sight Sciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sight Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Sight Stock media impact

There is far too much social signal, news, headlines, and media speculation about Sight Sciences that are available to investors today. This information is accessible both publicly - through Sight Sciences' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Sight-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Sight Sciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sight Sciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sight Sciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sight Sciences alpha.

Sight Sciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Sight Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Sight Sciences Historical Investor Sentiment

Investor biases related to Sight Sciences' public news can be used to forecast risks associated with an investment in Sight. The trend in average sentiment can be used to explain how an investor holding Sight can time the market purely based on public headlines and social activities around Sight Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Sight Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Sight Sciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Sight Sciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Sight Sciences.

Sight Sciences Corporate Management

Additional Tools for Sight Stock Analysis

When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.